Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Crédit Agricole SA (CAGR.PA)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (€)	Price Target (€)	Rating
2022-02-25	12.06	14.70	Buy
2022-03-28	10.74	13.40	Buy
2022-05-16	10.25	12.40	Buy
2022-09-01	9.02	12.30	Buy
2022-10-24	9.02	11.60	Buy
2022-11-16	9.53	10.00	Neutral
2022-11-22	9.70	-	No Rating
2022-11-23	9.70	10.00	Neutral
2023-01-13	10.49	10.20	Neutral
2023-03-07	11.40	11.20	Neutral
2023-04-24	10.98	11.50	Neutral
2023-06-09	10.83	11.70	Neutral
2023-10-13	11.40	12.20	Neutral
2024-01-04	13.14	13.70	Neutral
2024-02-15	12.23	13.00	Neutral
2024-04-19	14.04	13.90	Neutral
2024-05-14	15.66	15.60	Neutral
2024-07-17	13.72	15.60	Buy
2024-08-07	13.13	15.90	Buy
2024-10-10	13.88	15.30	Buy
2024-11-18	13.43	15.50	Buy
2025-01-09	13.44	15.90	Buy
2025-01-21	14.17	15.50	Buy
2025-02-05	14.68	16.80	Buy
2025-04-11	15.41	17.60	Buy

Disclosures

UBS has acted as manager/co-manager in the underwriting or placement of securities of this company/entity or one of its affiliates within the past 12 months.
Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
UBS expects to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.
This company/entity is, or within the past 12 months has been, a client of UBS Securities LLC, and non-investment banking securities-related services are being, or have been, provided.
This company/entity is, or within the past 12 months has been, a client of UBS Securities LLC, and non-securities services are being, or have been, provided.
Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.